Christopher Russell has broad transactional and corporate governance experience representing public and private companies at all stages of growth in a range of technology industries, as well as experience representing venture capital firms and financial institutions in investments in emerging growth companies. Mr. Russell represents emerging growth companies in private financings, ranging from seed-round financings to advanced-stage financings, as well as advising on corporate issues related to all aspects of an emerging-growth company's business, including mergers and acquisitions.
Mr. Russell also has significant expertise in private equity fund formation, and regularly advises general partners and institutional investors in connection with the formation of venture capital, real estate, buyout and other private equity funds. He has represented institutional investors and fund sponsors in the formation of approximately 100 domestic and foreign private equity funds and funds-of-funds. He also regularly advises fund sponsors on ongoing fund operations, upper-tier planning and regulatory compliance issues.
Mr. Russell serves on the board of directors of Sacramento Area Regional Technology Alliance (SARTA) and SARTA’s MedStart Advisory Committee. He also serves on the board of directors of WIND Youth Services.
Lipomics Technologies Merger.
Represented Lipomics Technologies in the merger with Tethys Bioscience. (2008)
American Pharmaceutical Partners $4.1 billion Acquisition
Represented American Pharmaceutical Partners, a public pharmaceutical company, in its $4.1 billion acquisition of privately-held American Bioscience.